StockNews.com Upgrades Maximus (NYSE:MMS) to Buy

Maximus (NYSE:MMSGet Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday.

Separately, Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd.

View Our Latest Analysis on Maximus

Maximus Trading Up 0.9 %

Shares of NYSE MMS opened at $75.99 on Wednesday. The firm’s 50 day moving average price is $74.66 and its 200-day moving average price is $84.09. Maximus has a 52-week low of $69.72 and a 52-week high of $93.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The company has a market cap of $4.58 billion, a PE ratio of 15.20 and a beta of 0.73.

Insider Transactions at Maximus

In other news, CEO Bruce Caswell acquired 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the completion of the acquisition, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Raymond B. Ruddy bought 3,490 shares of the stock in a transaction on Thursday, December 12th. The stock was purchased at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the acquisition, the director now owns 112,520 shares of the company’s stock, valued at $8,040,679.20. This trade represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 7,063 shares of company stock worth $502,017 over the last three months. 1.40% of the stock is currently owned by company insiders.

Institutional Trading of Maximus

Several large investors have recently added to or reduced their stakes in the business. Allworth Financial LP raised its position in Maximus by 1,638.4% in the fourth quarter. Allworth Financial LP now owns 1,495 shares of the health services provider’s stock worth $116,000 after acquiring an additional 1,409 shares during the period. Rhumbline Advisers raised its holdings in Maximus by 6.1% in the 4th quarter. Rhumbline Advisers now owns 205,259 shares of the health services provider’s stock worth $15,323,000 after purchasing an additional 11,772 shares during the period. V Square Quantitative Management LLC lifted its position in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 180 shares in the last quarter. Legato Capital Management LLC grew its holdings in Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock valued at $2,399,000 after purchasing an additional 8,138 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its position in Maximus by 2.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider’s stock worth $54,748,000 after buying an additional 16,772 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Company Profile

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.